Histone H2A.X signaling and chromatin remodeling in late erythropoiesis

晚期红细胞生成过程中的组蛋白 H2A.X 信号传导和染色质重塑

基本信息

  • 批准号:
    10432108
  • 负责人:
  • 金额:
    $ 30.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Erythropoiesis is a process of enormous magnitude, with the average adult producing approximately 2.5 million red blood cells each second. To maintain this impressive output, terminal erythroid maturation is coupled with rapid proliferation. In the span of 3-4 cell divisions, erythroid cells must condense their nuclei to approximately 1/10th of their original volume in anticipation of enucleation, which involves a dramatic compaction of the erythroid genome. Disruption this process is associated with myelodysplastic syndromes (MDS) and congenital anemias. The mechanisms involved, however, are poorly understood. Recent evidence from our group and others has implicated the variant histone H2A.X as an important component in normal erythroid maturation. Phosphorylation of this histone at S139 (γ-H2A.X) is an early feature of DNA repair pathways and contributes to the stability of broadly-distributed “foci” of DNA repair factors. Notably, we observe a burst of γ- H2A.X foci at a specific stage of erythroid maturation, concomitant with a significant increase in proliferation and replication rate, and with the final stages of nuclear condensation. Based on this and other observations, we hypothesize that histone H2A.X phosphorylation signals directly to downstream pathways that accomplish chromatin remodeling (through histone exchange) and compaction (through the induction of an apoptotic- related pathway). These studies will provide mechanistic insight into the still-opaque processes involved in terminal erythroid maturation, enhance our understanding of epigenetic gene regulation and chromatin compaction, and illuminate the basis for defects in erythropoiesis that can cause anemia.
红细胞生成是一个巨大的过程,成年人平均产生约250万个红细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL D BULGER其他文献

MICHAEL D BULGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL D BULGER', 18)}}的其他基金

Histone H2A.X signaling and chromatin remodeling in late erythropoiesis
晚期红细胞生成过程中的组蛋白 H2A.X 信号传导和染色质重塑
  • 批准号:
    10275305
  • 财政年份:
    2021
  • 资助金额:
    $ 30.21万
  • 项目类别:
Histone H2A.X signaling and chromatin remodeling in late erythropoiesis
晚期红细胞生成过程中的组蛋白 H2A.X 信号传导和染色质重塑
  • 批准号:
    10624464
  • 财政年份:
    2021
  • 资助金额:
    $ 30.21万
  • 项目类别:
Function of active chromatin domains in erythropoiesis
活性染色质结构域在红细胞生成中的功能
  • 批准号:
    7785719
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Enhancers and hyperacetylated domains in erythropoiesis
红细胞生成中的增强子和超乙酰化结构域
  • 批准号:
    8680225
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Function of active chromatin domains in erythropoiesis
活性染色质结构域在红细胞生成中的功能
  • 批准号:
    7566004
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Enhancers and hyperacetylated domains in erythropoiesis
红细胞生成中的增强子和超乙酰化结构域
  • 批准号:
    8838771
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Function of active chromatin domains in erythropoiesis
活性染色质结构域在红细胞生成中的功能
  • 批准号:
    7341105
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Function of active chromatin domains in erythropoiesis
活性染色质结构域在红细胞生成中的功能
  • 批准号:
    8034237
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Enhancers and hyperacetylated domains in erythropoiesis
红细胞生成中的增强子和超乙酰化结构域
  • 批准号:
    8503788
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:
Function of active chromatin domains in erythropoiesis
活性染色质结构域在红细胞生成中的功能
  • 批准号:
    7196385
  • 财政年份:
    2007
  • 资助金额:
    $ 30.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了